Home/Base4/Michael Pape
MP

Michael Pape

Head of Drug Development, Co-founder

Base4

Base4 Pipeline

DrugIndicationPhase
Undisclosed Neurology Program(s)Neurodegenerative DiseasesPreclinical
Undisclosed Oncology Program(s)OncologyPreclinical
Undisclosed Neuromuscular Program(s)Neuromuscular DisordersPreclinical
Undisclosed Rare Disease Program(s)Rare DiseasesPreclinical